Suppr超能文献

对照及突变培养皮肤成纤维细胞中硫苷脂/GM1激活蛋白(SAP-1)的生物合成

Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.

作者信息

Fujibayashi S, Wenger D A

出版信息

Biochim Biophys Acta. 1986 Feb 28;875(3):554-62. doi: 10.1016/0005-2760(86)90077-9.

Abstract

Sphingolipid activator proteins (SAP) are relatively low-molecular-mass proteins that stimulate the hydrolysis of specific sphingolipids by the required lysosomal enzymes. SAP-1 or sulfatide/GM1 ganglioside activator protein has previously been demonstrated to stimulate the enzymatic hydrolysis of sulfatide, GM1 ganglioside and globotriaosylceramide. Using monospecific rabbit antibodies against human liver sulfatide/GM1 activator, the biosynthesis and processing of this activator were studied in cultured skin fibroblasts from controls and patients with GM1 gangliosidosis and a variant form of metachromatic leukodystrophy. When [35S]methionine was presented in the medium to control human fibroblasts for 4 h, the majority of the immunoprecipitable radiolabeling was confined to bands within three regions of apparent molecular mass 65-70, 35-52 and 8-13 kDa. The only immunoprecipitable radiolabeled species excreted into the medium when NH4Cl was present had an apparent molecular mass of 70 kDa. When the excretion products were given to fresh cells followed by incubation for up to 24 h there was production of the mature species. Treatment of the 70 kDa form with endoglycosidase F resulted in production of a 53 kDa molecular mass form. Pulse-chase experiments indicated that the initial immunoprecipitable translation product was 65 kDa which increased to 70 kDa over the next hour. The 65 kDa species must result from co-translational glycosylation of the polypeptide chain. Apparently, intralysosomal processing converts the 13 kDa form to the 8-11 kDa species. The cells from the patient with GM1 gangliosidosis could not process to the smallest species found in controls due to the deficiency of acid beta-galactosidase. Patients who have a variant form of metachromatic leukodystrophy do not make any immunoprecipitable radiolabeled products in the cells or in the media. This indicates a severe mutation in the gene coding for this activator protein. The production of such small mature species from a relatively large precursor form may regulate the production of this interesting protein.

摘要

鞘脂激活蛋白(SAP)是相对低分子量的蛋白质,可刺激所需的溶酶体酶对特定鞘脂的水解。先前已证明,SAP-1或硫苷脂/GM1神经节苷脂激活蛋白可刺激硫苷脂、GM1神经节苷脂和球三糖神经酰胺的酶促水解。使用针对人肝脏硫苷脂/GM1激活剂的单特异性兔抗体,在来自对照以及患有GM1神经节苷脂病和一种异染性脑白质营养不良变体形式的患者的培养皮肤成纤维细胞中研究了这种激活剂的生物合成和加工过程。当在培养基中向对照人成纤维细胞提供[35S]甲硫氨酸4小时时,大部分可免疫沉淀的放射性标记局限于表观分子量为65-70、35-52和8-13 kDa的三个区域内的条带。当存在NH4Cl时,分泌到培养基中的唯一可免疫沉淀的放射性标记物种的表观分子量为70 kDa。当将排泄产物给予新鲜细胞并孵育长达24小时时,会产生成熟物种。用内切糖苷酶F处理70 kDa形式会产生53 kDa分子量的形式。脉冲追踪实验表明,最初可免疫沉淀的翻译产物为65 kDa,在接下来的一小时内增加到70 kDa。65 kDa物种必定是多肽链共翻译糖基化的结果。显然,溶酶体内加工将13 kDa形式转化为8-11 kDa物种。由于酸性β-半乳糖苷酶缺乏,GM1神经节苷脂病患者的细胞无法加工成对照中发现的最小物种。患有异染性脑白质营养不良变体形式的患者在细胞或培养基中不会产生任何可免疫沉淀的放射性标记产物。这表明编码这种激活蛋白的基因发生了严重突变。从相对较大的前体形式产生如此小的成熟物种可能会调节这种有趣蛋白质的产生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验